IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v475y2011i7355d10.1038_nature10167.html
   My bibliography  Save this article

Selective killing of cancer cells by a small molecule targeting the stress response to ROS

Author

Listed:
  • Lakshmi Raj

    (Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School)

  • Takao Ide

    (Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School)

  • Aditi U. Gurkar

    (Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School)

  • Michael Foley

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Monica Schenone

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Xiaoyu Li

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Nicola J. Tolliday

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Todd R. Golub

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Steven A. Carr

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Alykhan F. Shamji

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Andrew M. Stern

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Anna Mandinova

    (Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School
    Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Stuart L. Schreiber

    (Broad Institute of Harvard and MIT, 7 Cambridge Center)

  • Sam W. Lee

    (Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School
    Broad Institute of Harvard and MIT, 7 Cambridge Center)

Abstract

ROS-mediated anticancer compound A chemical screen has identified a small molecule, piperlongumine (PL), as a compound that induces selective killing of cancer cells. Piperlongumine acts by increasing reactive oxygen species (ROS) levels in cancer cells. Although it is active against a number of tumour models in vivo irrespective of p53 status, it does not affect normal tissues, including rapidly proliferating non-tumour cells. This work suggests a novel strategy for eradicating cancer cells by targeting the ROS stress-response pathway, but further work will be needed to identify determinants of piperlongumine sensitivity in a wider range of cancers.

Suggested Citation

  • Lakshmi Raj & Takao Ide & Aditi U. Gurkar & Michael Foley & Monica Schenone & Xiaoyu Li & Nicola J. Tolliday & Todd R. Golub & Steven A. Carr & Alykhan F. Shamji & Andrew M. Stern & Anna Mandinova & S, 2011. "Selective killing of cancer cells by a small molecule targeting the stress response to ROS," Nature, Nature, vol. 475(7355), pages 231-234, July.
    • Handle: RePEc:nat:nature:v:475:y:2011:i:7355:d:10.1038_nature10167
    DOI: 10.1038/nature10167
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature10167
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature10167?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Hanjie Zhang & Yitong Zhang & Yushi Zhang & Hanyue Li & Meitong Ou & Yongkang Yu & Fan Zhang & Huijuan Yin & Zhuo Mao & Lin Mei, 2024. "Catalytic activity of violet phosphorus-based nanosystems and the role of metabolites in tumor therapy," Nature Communications, Nature, vol. 15(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:475:y:2011:i:7355:d:10.1038_nature10167. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.